Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Molecules , 19 (11), 1906619077
Team up with healthcare providers to get the right dose at the best time
Elevated NAD+ activates sirtuin deacetylases
The work still happens naturally, but with better support behind it
Remarkable Results The findings were impressive: BPC-157 Only Group (12 patients): 11 out of 12 patients (91.6%) experienced significant improvement Only 1 patient (8.3%) saw no improvement BPC-157 + TB4 Combination Group (4 patients): 3 out of 4 patients (75%) showed significant improvement 1 patient (25%) experienced no relief Overall Success Rate : 14 out of 16 patients (87.5%) found relief from their knee pain What Makes BPC-157 Different from Traditional Treatments
Yuying Luo, MD Medical Reviewer Yuying Luo, MD, is an assistant professor of medicine at Mount Sinai West and Morningside in New York City
